Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
2(100.0%)
2Total
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06938516Recruiting

Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)

Role: lead

NCT03895762Completed

Observational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer Patients

Role: lead

NCT03847350Completed

Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential Hypertension

Role: lead

NCT03633760Phase 1Unknown

Different Level of Single-dose and Multiple-dose Bilastine PK Study in Chinese Population

Role: lead

NCT02817932Phase 1Unknown

A Study of Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects

Role: lead

All 5 trials loaded